-
Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 60 Years with Cardiopulmonary Disease
Mar 10, 2025, 14:00 PM -
Using Artificial Intelligence to Predict Patient's Preferences
Mar 10, 2025, 14:00 PM -
Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM -
Quality of Life Assessment of Patients Undergoing Hip Replacement Surgery in the Public and Private Healthcare Systems
Mar 10, 2025, 14:00 PM -
National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States
Mar 10, 2025, 14:00 PM -
Concomitant Usage of Contra-Indicated Medications in Patients With Atrial Fibrillation: A Comparison of Real-World Data Sources in the United States
Mar 10, 2025, 14:00 PM -
Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Other Similar Measures? – How Different Really Are QALYs From Life Years, Health Years in Total, and Equal Value Life Years?
Mar 10, 2025, 14:00 PM -
Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
Comparing the Cost-Utility of Renal Replacement Therapies Delivered to Critically Ill Patients With Acute Kidney Injury in the United States
Mar 10, 2025, 14:00 PM -
Clinical Trial Participant and Clinician Experience in a Phase 2 (US-only) Trial of MM120 for Generalized Anxiety Disorder
Mar 10, 2025, 14:00 PM -
Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database
Mar 10, 2025, 14:00 PM -
Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Telehealth for Disease Management: A Scoping Review of Effectiveness in the Perinatal Period
Mar 10, 2025, 14:00 PM -
Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans
Mar 10, 2025, 14:00 PM -
Unmet Needs and Evidence Gaps Among Patients with DLBCL treated with CAR-T Therapy: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access
Mar 10, 2025, 14:00 PM -
Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy for Treatment-Naive Patients of Extensive-Stage Small Cell Lung Cancer without Brain Metastasis
Mar 10, 2025, 14:00 PM -
Facilitating Effective Implementation of Qualitative in Trial Interviews
Mar 10, 2025, 14:00 PM
